AVEO Oncology
Pre-clinicalAVEO Oncology develops and commercializes targeted cancer therapies, advancing innovative oncology treatments through research to improve patient outcomes.
Founded
2002
Focus
Small Molecules
About
AVEO Oncology develops and commercializes targeted cancer therapies, advancing innovative oncology treatments through research to improve patient outcomes.
Funding History
5Total raised: $280.6M
PIPE$53MNovo A/SJun 15, 2013
Series C$107MBiopartner FundJun 15, 2010
IPO$81.6MUndisclosedFeb 11, 2010
Series B$33MMPM CapitalJun 15, 2007
Company Info
TypePrivate
Founded2002
LocationBoston, United States
StagePre-clinical
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile